Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
687 Pharmacokinetic Study (A2210378) Comparing Two Pediatric Paracetamol Suspensions Shows Bioequivalence, and Faster Early Absorption of New Formulation
Objective: To compare a new formulation, Paracetamol Pediatric Suspension (PPS), designed to reach therapeutic levels rapidly, to marketed formulations of Children's Panadol® (CP) and Panodil® Baby & Infant Su...